Inflammatory Markers in Alzheimer's Disease
Author Information
Author(s): Kim Sam-Moon, Song Juhee, Kim Seungwoo, Han Changsu, Park Moon Ho, Koh Youngho, Jo Sangmee Ahn, Kim Young-Youl
Primary Institution: Center for Biomedical Science, Division of Brain Diseases, National Institute of Health in Korea
Hypothesis
Can peripheral inflammatory markers help differentiate between normal controls and Alzheimer's disease?
Conclusion
The study suggests that lower plasma IL-8 levels are associated with functional status in patients with mild cognitive impairment and Alzheimer's disease.
Supporting Evidence
- IL-8 levels were significantly lower in MCI and AD patients compared to normal controls.
- Educational years were correlated with diagnosis states.
- No significant differences in cardiovascular disease, BMI, and NSAID use were found between MCI or AD groups and normal controls.
Takeaway
This study looked at blood markers to see if they can help tell if someone has Alzheimer's disease. They found that a specific marker, IL-8, was lower in people with Alzheimer's.
Methodology
Plasma samples and clinical data were obtained from participants in the Ansan Geriatric Study, measuring levels of IL-8, IL-10, MCP-1, and TNF-α.
Limitations
The study did not include severe Alzheimer's cases, limiting the ability to assess cytokine levels in advanced disease.
Participant Demographics
The study included 59 elderly participants, with 21 normal controls, 20 with mild cognitive impairment, and 18 with Alzheimer's disease.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website